Your browser doesn't support javascript.
Supervised Machine Learning Approach to Identify Early Predictors of Poor Outcome in Patients with COVID-19 Presenting to a Large Quaternary Care Hospital in New York City.
Zucker, Jason; Gomez-Simmonds, Angela; Purpura, Lawrence J; Shoucri, Sherif; LaSota, Elijah; Morley, Nicholas E; Sovic, Brit W; Castellon, Marvin A; Theodore, Deborah A; Bartram, Logan L; Miko, Benjamin A; Scherer, Matthew L; Meyers, Kathrine A; Turner, William C; Kelly, Maureen; Pavlicova, Martina; Basaraba, Cale N; Baldwin, Matthew R; Brodie, Daniel; Burkart, Kristin M; Bathon, Joan; Uhlemann, Anne-Catrin; Yin, Michael T; Castor, Delivette; Sobieszczyk, Magdalena E.
  • Zucker J; Division of Infectious Diseases, Columbia University Irving Medical Center, New York, NY 10032, USA.
  • Gomez-Simmonds A; Division of Infectious Diseases, Columbia University Irving Medical Center, New York, NY 10032, USA.
  • Purpura LJ; Division of Infectious Diseases, Columbia University Irving Medical Center, New York, NY 10032, USA.
  • Shoucri S; Division of Infectious Diseases, Columbia University Irving Medical Center, New York, NY 10032, USA.
  • LaSota E; Tulane University School of Medicine, Tulane Medical Center, New Orleans, LA 70112, USA.
  • Morley NE; Columbia University Vagelos College of Physicians and Surgeons, Columbia University Irving Medical Center, New York, NY 10032, USA.
  • Sovic BW; Division of Infectious Diseases, Columbia University Irving Medical Center, New York, NY 10032, USA.
  • Castellon MA; Division of Infectious Diseases, Columbia University Irving Medical Center, New York, NY 10032, USA.
  • Theodore DA; Division of Infectious Diseases, Columbia University Irving Medical Center, New York, NY 10032, USA.
  • Bartram LL; Division of Infectious Diseases, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
  • Miko BA; Division of Infectious Diseases, Columbia University Irving Medical Center, New York, NY 10032, USA.
  • Scherer ML; Division of Infectious Diseases, Columbia University Irving Medical Center, New York, NY 10032, USA.
  • Meyers KA; Aaron Diamond AIDS Research Center, Vagelos College of Physicians and Surgeons, New York, NY 10032, USA.
  • Turner WC; General Internal Medicine, Columbia University Irving Medical Center, New York, NY 10032, USA.
  • Kelly M; General Internal Medicine, Columbia University Irving Medical Center, New York, NY 10032, USA.
  • Pavlicova M; Mailman School of Public Health, Columbia University Irving Medical Center, New York, NY 10032, USA.
  • Basaraba CN; Mailman School of Public Health, Columbia University Irving Medical Center, New York, NY 10032, USA.
  • Baldwin MR; Division of Pulmonology, Columbia University Irving Medical Center, New York, NY 10032, USA.
  • Brodie D; Division of Pulmonology, Columbia University Irving Medical Center, New York, NY 10032, USA.
  • Burkart KM; Division of Pulmonology, Columbia University Irving Medical Center, New York, NY 10032, USA.
  • Bathon J; Division of Rheumatology, Columbia University Irving Medical Center, New York, NY 10032, USA.
  • Uhlemann AC; Division of Infectious Diseases, Columbia University Irving Medical Center, New York, NY 10032, USA.
  • Yin MT; Division of Infectious Diseases, Columbia University Irving Medical Center, New York, NY 10032, USA.
  • Castor D; Division of Infectious Diseases, Columbia University Irving Medical Center, New York, NY 10032, USA.
  • Sobieszczyk ME; Division of Infectious Diseases, Columbia University Irving Medical Center, New York, NY 10032, USA.
J Clin Med ; 10(16)2021 Aug 11.
Article in English | MEDLINE | ID: covidwho-1354993
ABSTRACT

BACKGROUND:

The progression of clinical manifestations in patients with coronavirus disease 2019 (COVID-19) highlights the need to account for symptom duration at the time of hospital presentation in decision-making algorithms.

METHODS:

We performed a nested case-control analysis of 4103 adult patients with COVID-19 and at least 28 days of follow-up who presented to a New York City medical center. Multivariable logistic regression and classification and regression tree (CART) analysis were used to identify predictors of poor outcome.

RESULTS:

Patients presenting to the hospital earlier in their disease course were older, had more comorbidities, and a greater proportion decompensated (<4 days, 41%; 4-8 days, 31%; >8 days, 26%). The first recorded oxygen delivery method was the most important predictor of decompensation overall in CART analysis. In patients with symptoms for <4, 4-8, and >8 days, requiring at least non-rebreather, age ≥ 63 years, and neutrophil/lymphocyte ratio ≥ 5.1; requiring at least non-rebreather, IL-6 ≥ 24.7 pg/mL, and D-dimer ≥ 2.4 µg/mL; and IL-6 ≥ 64.3 pg/mL, requiring non-rebreather, and CRP ≥ 152.5 mg/mL in predictive models were independently associated with poor outcome, respectively.

CONCLUSION:

Symptom duration in tandem with initial clinical and laboratory markers can be used to identify patients with COVID-19 at increased risk for poor outcomes.
Keywords

Full text: Available Collection: International databases Database: MEDLINE Type of study: Cohort study / Observational study / Prognostic study Language: English Year: 2021 Document Type: Article Affiliation country: Jcm10163523

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Type of study: Cohort study / Observational study / Prognostic study Language: English Year: 2021 Document Type: Article Affiliation country: Jcm10163523